bringing novel agents to the frontline setting in myeloma
Published 2 years ago • 99 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:50
the value of moving novel agents into the frontline setting in all
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
2:53
novel targets and dual-targeting approaches in myeloma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
2:09
integrating novel agents into the treatment of multiple myeloma
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
9:25
mgus diagnosis: a step-by-step approach
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
0:56
new additions: novel agents to boost treatment of multiple myeloma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:33
novel targets being explored in multiple myeloma and the value of celmods
-
1:11
incorporating novel therapies into frontline all treatment
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
1:01
an update on the phase i trial of bms-986393, a novel gprc5d-targeted car-t, in r/r myeloma
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
1:02
promising novel targets emerging in myeloma & the value of combining agents